Skip to content

XOMA Corporation XOMA Royalty And Commercial Payment Receivables Cost Recovery Method Long Term

Royalty And Commercial Payment Receivables Cost Recovery Method Long Term at other companies

Omeros logo
OmerosOMER
$93.72M-22.9%
Royal Gold logo
Royal GoldRGLD
$142.8M+147%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$193.54M+2.8%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$50M0.0%
Omeros logo
OmerosOMER
$25.48M-12.8%
Ramaco Resources logo
Ramaco ResourcesMETC
$6.26M+22.1%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept xoma:RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodLongTerm.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's royalty and commercial payment receivables cost recovery method long term.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's royalty and commercial payment receivables cost recovery method long term?
XOMA Corporation (XOMA) reported royalty and commercial payment receivables cost recovery method long term of $55.89M in Q1 2026.
How has XOMA Corporation's royalty and commercial payment receivables cost recovery method long term changed year-over-year?
XOMA Corporation's royalty and commercial payment receivables cost recovery method long term decreased by 6.7% year-over-year, from $59.92M to $55.89M.
What is the long-term trend for XOMA Corporation's royalty and commercial payment receivables cost recovery method long term?
Over 2 years (2023 to 2025), XOMA Corporation's royalty and commercial payment receivables cost recovery method long term has grown at a -1.8% compound annual growth rate (CAGR), from $57.95M to $55.89M.
What does royalty and commercial payment receivables cost recovery method long term mean?
This represents the long-term portion of royalty and commercial payment receivables accounted for under the cost recovery method. It reflects the carrying value of investments where future cash flows are expected to be realized beyond one year, following the recovery of initial capital. Monitoring this metric provides insight into the long-term pipeline of potential revenue-generating assets.